<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rivera-Gonzalez O</submitter><funding>NIDDK NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>e14214</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11421981</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>240(10)</volume><pubmed_abstract>&lt;h4>Aims&lt;/h4>Endothelin-1 (ET-1) is elevated in patients with obesity and adipose tissue of obese mice fed high-fat diet (HFD); however, its contribution to the pathophysiology of obesity is not fully understood. Genetic loss of endothelin type B receptors (ET&lt;sub>B&lt;/sub>) improves insulin sensitivity in rats and leads to increased circulating adiponectin, suggesting that ET&lt;sub>B&lt;/sub> activation on adipocytes may contribute to obesity pathophysiology. We hypothesized that elevated ET-1 in obesity promotes insulin resistance by reducing the secretion of insulin sensitizing adipokines, via ET&lt;sub>B&lt;/sub> receptor.&lt;h4>Methods&lt;/h4>Male adipocyte-specific ET&lt;sub>B&lt;/sub> receptor knockout (adET&lt;sub>B&lt;/sub>KO), overexpression (adET&lt;sub>B&lt;/sub>OX), or control littermates were fed either normal diet (NMD) or high-fat diet (HFD) for 8 weeks.&lt;h4>Results&lt;/h4>RNA-sequencing of epididymal adipose (eWAT) indicated differential expression of over 5500 genes (p &lt; 0.05) in HFD compared to NMD controls, and changes in 1077 of these genes were attenuated in HFD adET&lt;sub>B&lt;/sub>KO mice. KEGG analysis indicated significant increase in metabolic signaling pathway. HFD adET&lt;sub>B&lt;/sub>KO mice had significantly improved glucose and insulin tolerance compared to HFD control. In addition, adET&lt;sub>B&lt;/sub>KO attenuated changes in plasma adiponectin, insulin, and leptin that is observed in HFD versus NMD control mice. Treatment of primary adipocytes with ET-1 caused a reduction in adiponectin production that was attenuated in cells pretreated with an ET&lt;sub>B&lt;/sub> antagonist.&lt;h4>Conclusion&lt;/h4>These data indicate elevated ET-1 in adipose tissue of mice fed HFD inhibits adiponectin production and causes insulin resistance through activation of the ET&lt;sub>B&lt;/sub> receptor on adipocytes.</pubmed_abstract><journal>Acta physiologica (Oxford, England)</journal><pubmed_title>Adipocyte endothelin B receptor activation inhibits adiponectin production and causes insulin resistance in obese mice.</pubmed_title><pmcid>PMC11421981</pmcid><funding_grant_id>U2C DK133422</funding_grant_id><funding_grant_id>P20 GM144041</funding_grant_id><funding_grant_id>P30 GM149404</funding_grant_id><funding_grant_id>P01 HL158500</funding_grant_id><funding_grant_id>R01 DK124327</funding_grant_id><funding_grant_id>P20 GM104357</funding_grant_id><funding_grant_id>T32 HL105324</funding_grant_id><funding_grant_id>F31 DK125035</funding_grant_id><funding_grant_id>P20 GM103476</funding_grant_id><funding_grant_id>R01 DK126664</funding_grant_id><funding_grant_id>U54 GM115428</funding_grant_id><pubmed_authors>Garrett MR</pubmed_authors><pubmed_authors>Speed JS</pubmed_authors><pubmed_authors>Wilson NA</pubmed_authors><pubmed_authors>Webb DJ</pubmed_authors><pubmed_authors>Rivera-Gonzalez O</pubmed_authors><pubmed_authors>Konadu BD</pubmed_authors><pubmed_authors>Murphy HA</pubmed_authors><pubmed_authors>Mills MF</pubmed_authors><pubmed_authors>Hyndman KA</pubmed_authors><pubmed_authors>Newberry MK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Adipocyte endothelin B receptor activation inhibits adiponectin production and causes insulin resistance in obese mice.</name><description>&lt;h4>Aims&lt;/h4>Endothelin-1 (ET-1) is elevated in patients with obesity and adipose tissue of obese mice fed high-fat diet (HFD); however, its contribution to the pathophysiology of obesity is not fully understood. Genetic loss of endothelin type B receptors (ET&lt;sub>B&lt;/sub>) improves insulin sensitivity in rats and leads to increased circulating adiponectin, suggesting that ET&lt;sub>B&lt;/sub> activation on adipocytes may contribute to obesity pathophysiology. We hypothesized that elevated ET-1 in obesity promotes insulin resistance by reducing the secretion of insulin sensitizing adipokines, via ET&lt;sub>B&lt;/sub> receptor.&lt;h4>Methods&lt;/h4>Male adipocyte-specific ET&lt;sub>B&lt;/sub> receptor knockout (adET&lt;sub>B&lt;/sub>KO), overexpression (adET&lt;sub>B&lt;/sub>OX), or control littermates were fed either normal diet (NMD) or high-fat diet (HFD) for 8 weeks.&lt;h4>Results&lt;/h4>RNA-sequencing of epididymal adipose (eWAT) indicated differential expression of over 5500 genes (p &lt; 0.05) in HFD compared to NMD controls, and changes in 1077 of these genes were attenuated in HFD adET&lt;sub>B&lt;/sub>KO mice. KEGG analysis indicated significant increase in metabolic signaling pathway. HFD adET&lt;sub>B&lt;/sub>KO mice had significantly improved glucose and insulin tolerance compared to HFD control. In addition, adET&lt;sub>B&lt;/sub>KO attenuated changes in plasma adiponectin, insulin, and leptin that is observed in HFD versus NMD control mice. Treatment of primary adipocytes with ET-1 caused a reduction in adiponectin production that was attenuated in cells pretreated with an ET&lt;sub>B&lt;/sub> antagonist.&lt;h4>Conclusion&lt;/h4>These data indicate elevated ET-1 in adipose tissue of mice fed HFD inhibits adiponectin production and causes insulin resistance through activation of the ET&lt;sub>B&lt;/sub> receptor on adipocytes.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2026-06-03T23:18:51.783Z</modification><creation>2026-05-03T03:10:24.72Z</creation></dates><accession>S-EPMC11421981</accession><cross_references><pubmed>39096077</pubmed><doi>10.1111/apha.14214</doi></cross_references></HashMap>